Manager, Cell Therapy Manufacturing at Cellares

South San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Cell TherapyIndustries

Requirements

Candidates should possess a Bachelor’s degree in a relevant scientific field, such as Biology, Chemistry, or Engineering, and have a minimum of 7 years of experience in cell therapy manufacturing, with at least 3 years in a leadership role. Demonstrated knowledge of cGMP regulations and cell therapy manufacturing processes is essential, along with strong leadership and communication skills.

Responsibilities

The Manager, Cell Therapy Manufacturing will lead, direct, and develop a manufacturing team responsible for the daily clinical and production of autologous and allogeneic cell therapy products, ensuring safe and compliant operations according to cGMP requirements. They will monitor and improve production metrics, oversee hiring and development of staff, lead audits, collaborate with stakeholders, and ensure manufacturing processes adhere to protocols and SOPs. Additionally, the role involves revising documentation, investigating deviations, and contributing to analysis and presentation of technical results.

Skills

cGMP

Cell Therapy Manufacturing

Manufacturing Leadership

Team Management

GMP Compliance

Audits

Production Metrics

Stakeholder Collaboration

Hiring

Performance Management

Autologous Cell Therapy

Allogeneic Cell Therapy

Cellares

Develops and manufactures cell therapies efficiently

About Cellares

Cellares develops and manufactures cell therapies in the biotechnology sector, operating as an Integrated Development and Manufacturing Organization (IDMO). Its proprietary "Smart Factory" technology features an automated single-use cartridge system, which increases productivity and reduces costs and process failures compared to traditional methods. The company serves a range of clients, including pharmaceutical companies, and aims to provide efficient and cost-effective manufacturing services for cell therapies. Cellares stands out by combining development and manufacturing processes under one roof, making it a competitive option in the industry.

South San Francisco, CaliforniaHeadquarters

2019Year Founded

$345.3MTotal Funding

SERIES_CCompany Stage

Industrial & Manufacturing, BiotechnologyIndustries

201-500Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Stock Options

Risks

Emerging biotech startups threaten Cellares' market share with similar solutions.

Potential regulatory delays could impact scaling of new automated systems like Cell Q.

Supply chain vulnerabilities may disrupt production timelines for Cell Shuttle and Cell Q.

Differentiation

Cellares' Cell Shuttle offers 10x scalability over manual cell therapy manufacturing.

The Smart Factory technology integrates development and manufacturing, unlike traditional CDMOs.

Cell Q automates QC processes, addressing bottlenecks in cell therapy quality control.

Upsides

Partnership with Sony enhances precision in cell therapy manufacturing processes.

Strategic partnership with Bristol Myers Squibb provides financial boost and validation.

Ossama Eissa's appointment as COO accelerates global expansion and operational capabilities.

Land your dream remote job 3x faster with AI

Try Jobo Free